TCON TRACON Pharmaceuticals Operatsion marja

TCON (TRACON Pharmaceuticals Inc.) - kompaniyaning tovar belgisi

Muvaffaqiyatsiz sinovlardan keyingi to'liq inqiroz TRACON Pharmaceuticals (TCON) aktivlarining tugatilishiga olib keldi. GURU.Markets platformasidagi operatsion daromad koeffitsiyenti ushbu pasayishni vizuallashtiradi, bunda 0.00 qiymati joriy ko'lamni ko'rsatadi. Avvalroq, biznes onkologik dori vositalari va o'simta terapiyasi uchun antitanachlarning ishlab chiqilishiga tayangan edi. Kapitalizatsiya saratonning kamyob shakllarini davolovchi hamkorlardan olingan royalti to'lovlari va oldindan to'lovlarga asoslangan edi.

TCON: TRACON Pharmaceuticals Inc. Sotuvning operatsion rentabelligi 04.07.2022 - 04.08.2024

TRACON Pharmaceuticals (TCON) moliyaviy va bozor koʻrsatkichlari kesimi

- aksiya narxi va baholash bo'yicha konsensus prognoz:
Kompaniyaning dastlabki tahlili:TRACON Pharmaceuticals, Inc, TCON
TRACON Pharmaceuticals, Inc brendining mahsuloti

Barqaror savdoning yo'qligi va tashqi kapitalga bog'liqlik bilan tavsiflanuvchi TRACON Pharmaceuticals (TCON) sog'liqni saqlash giganti biofarmatsevtika sektori uchun operatsion marja xarajatlar nazoratining muhim ko'rsatkichi bo'lib xizmat qiladi. Operatsion samaradorlik darajasini tahlil qilishda investor operatsion foydaning daromadga nisbatini baholaydi, bunda grafikdagi keskin tebranishlar ko'pincha samaradorlikning vaqtincha oshishi va keyinchalik o'rtacha ko'rsatkichka qaytishdan dalolat beradi.

Raqobatdosh kompaniyalar tahlili

Sotuvning operatsion marjasi TEM|QGEN - Operatsion foyda bo'yicha marjinallik|Operatsion marja IONS|RGEN - Sotuvning operatsion rentabelligi|Operatsion rentabellik Avidity RNA|Operatsion marja CRISPR Therapeutics Corp CRSP|GeneDx Corp - Operatsion marja|Ultragenyx Pharma (RARE) - Sotuvning operatsion marjasi|beamtx.com (BEAM) - Operatsion rentabellik|SRPT: Operatsion foyda koeffitsiyenti|Sotuvning operatsion marjasi TWST|TXG - Operatsion foyda bo'yicha marjinallik|Operatsion marja NTLA|Operatsion faoliyat rentabelligi Stoke Therapeutics|Operatsion rentabellik BioLife Solutions BLFS|Wave Life Sciences (WVE) - Sotuvning operatsion rentabelligi|Maze Therapeutics, Inc. - Operatsion marja|Operatsion faoliyat rentabelligi Sionna Therapeutics, Inc. SION|Prime Medicine Bio (PRME) - Operatsion rentabellik|TSHA: Operatsion foyda koeffitsiyenti|Operatsion rentabellik uniQure Pharma|MGTX - Operatsion foyda bo'yicha marjinallik|Operatsion marja RGNX|Operatsion rentabellik SLDB (Solid Biosciences)|Ocugen Corp - Sotuvning operatsion marjasi|PACB: Operatsion foyda bo'yicha sotuv rentabelligi|benitec.com - Operatsion marja|DSGN - Operatsion marja|RCKT: Operatsion marja|FDMT (4D Molecular Therapeutics Inc) - Operatsion rentabellik|Sotuvning operatsion marjasi LXEO|Operatsion rentabellik KRRO|Operatsion marja EDIT|SLN - Sotuvning operatsion rentabelligi|Operatsion marja PRQR (ProQR)|CDXS - Sotuvning operatsion marjasi|Sangamo Therapeutics Inc. - Operatsion marja|NAUT - Operatsion marja|MGX: Operatsion marja|Sotuvning operatsion marjasi Precision BioSciences, Inc.|GBIO (Generation Bio) - Operatsion marja|Boundless Bio Inc. (BOLD) - Operatsion faoliyat rentabelligi|Sotuvning operatsion marjasi XCUR (exicuretx.com)|Imunon Inc - Operatsion foyda bo'yicha sotuv rentabelligi|Operatsion marja PHIO (Phio Pharmaceuticals Corp)|Operatsion foyda normasi MBIO|RNAZ - Operatsion rentabellik|Operatsion foyda normasi BNGO (bionanogenomics.com)|Applied DNA Sciences (APDN) - Operatsion rentabellik|Bluebird Bio - Operatsion foyda normasi|IPA (ImmunoPrecise Antibodies Ltd) - Operatsion marja|Sotuvning operatsion rentabelligi Omega Therapeutics, Inc. OMGA|Operatsion marja OMIC|RGLS (Regulus Therapeutics Inc.) - Operatsion foyda normasi|Operatsion marja SYRS (Syros Pharmaceuticals Inc.)|Operatsion foyda koeffitsiyenti TBIO (Codex DNA)|UBX - Operatsion rentabellik